Clinical trial
Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
NCT00004251 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00004251 |
|---|---|
| Title | Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer |
| Official title | A Phase II Study of Letrozole in Patients With Advanced or Recurrent Endometrial Cancer |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometrial Cancer |
| Intervention type | Drug |
| Interventions | letrozole |
| Enrollment | 33 |
| Start date | Jan 19, 2000 |
| Primary completion | Sep 13, 2002 |
| Completion | Jan 18, 2011 |
| First posted | Jun 17, 2004 |
| Last update posted | Apr 6, 2020 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: